Cargando…

P2Y12 Antiplatelet Choice for Patients with Chronic Kidney Disease and Acute Coronary Syndrome: A Systematic Review and Meta-Analysis

This study aims to evaluate potentially appropriate antiplatelet therapy in patients with chronic kidney disease. A systematic analysis was conducted to identify the clinical outcomes of available antiplatelet therapy regimens with enhanced platelet inhibition activity (intervention of 5 regimens) o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sohyun, Choi, Yeo Jin, Kang, Ji Eun, Kim, Myeong Gyu, Jung Geum, Min, Kim, So Dam, Rhie, Sandy Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004167/ https://www.ncbi.nlm.nih.gov/pubmed/33801161 http://dx.doi.org/10.3390/jpm11030222

Ejemplares similares

Validation of a Questionnaire for Patient Awareness and the Need for a Community-Based Outpatient Antimicrobial Stewardship Program (O-ASP): A Pilot Study
por: Park, Sohyun, et al.
Publicado: (2021)

Signal Detection of Adverse Drug Reactions of Cephalosporins Using Data from a National Pharmacovigilance Database
por: Choi, Jung-Yoon, et al.
Publicado: (2021)

Antimicrobial Stewardship Programs in Community Health Systems Perceived by Physicians and Pharmacists: A Qualitative Study with Gap Analysis
por: Park, Sohyun, et al.
Publicado: (2019)

Clinical outcomes of renin angiotensin system inhibitor-based dual antihypertensive regimens in chronic kidney disease: a network meta-analysis
por: Cho, Miseung, et al.
Publicado: (2023)

Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with solvent-based taxanes for metastatic breast cancer: A meta-analysis
por: Lee, Hwaryeon, et al.
Publicado: (2020)

Broad-Spectrum Antibiotic Regimen Affects Survival in Patients Receiving Nivolumab for Non-Small Cell Lung Cancer
por: Geum, Min Jung, et al.
Publicado: (2021)

Impact of preprocedural coronary flow grade on duration of dual antiplatelet therapy in acute myocardial infarction
por: Kim, Yong Hoon, et al.
Publicado: (2021)

Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy
por: Choi, Jae Hee, et al.
Publicado: (2021)

Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction
por: Roh, Ji Woong, et al.
Publicado: (2021)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Tolerability on Serious Adverse Events of First-Line Bevacizumab and Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Han, Yu Na, et al.
Publicado: (2022)

Sex-Based Outcomes of P2Y12 Inhibitor Monotherapy After Three Months of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
por: Shin, Eun-Seok, et al.
Publicado: (2023)

Safety Assessment on Serious Adverse Events of Targeted Therapeutic Agents Prescribed for RAS Wild-Type Metastatic Colorectal Cancer: Systematic Review and Network Meta-Analysis
por: Choi, Yeo Jin, et al.
Publicado: (2022)

The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
por: Choi, Woong Gil, et al.
Publicado: (2021)

Trends in antiplatelet strategies 12-months following coronary stent placement in anticoagulated patients
por: Gamvroulas, Eleni M., et al.
Publicado: (2023)

Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
por: Mshelbwala, Fakilahyel S, et al.
Publicado: (2020)

Molecular Neuroimaging in Posttraumatic Stress Disorder
por: Im, Jooyeon Jamie, et al.
Publicado: (2016)

Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI
por: Ki, You-Jeong, et al.
Publicado: (2021)

The influence of a patient counseling training session on pharmacy students’ self-perceived communication skills, confidence levels, and attitudes about communication skills training
por: Jin, Hye Kyung, et al.
Publicado: (2019)

Triple Antiplatelet Therapy with Cilostazol and Favorable Early Clinical Outcomes after Acute Myocardial Infarction Compared to Dual Antiplatelet Therapy with Standard or Potent P2Y12 Inhibitors
por: Byun, Sungwook, et al.
Publicado: (2022)

Antiplatelet and antithrombotic effect of Phyllostachys pubescens leaves and Mume Fructus combination
por: Jin, Wen Yi, et al.
Publicado: (2013)

The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease
por: Kim, Hyun Jung, et al.
Publicado: (2017)

Antiplatelet Therapy and Percutaneous Coronary Interventions
por: Davanzo, Rene Hameau, et al.
Publicado: (2021)

Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease
por: Kao, Chih-Chin, et al.
Publicado: (2021)

Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE review
por: Jeong, Sohyun, et al.
Publicado: (2016)

Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease
por: Pang, Chang Hwan, et al.
Publicado: (2021)

Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion
por: Lee, Seung Hwa, et al.
Publicado: (2017)

Antitcoagulant and antiplatelet activities of scolymoside
por: Yoon, Eun-Kyung, et al.
Publicado: (2015)

Long-term Outcomes of Clopidogrel Monotherapy versus Prolonged Dual Antiplatelet Therapy beyond 12 Months after Percutaneous Coronary Intervention in High-risk Patients
por: Kim, Dong-Yeon, et al.
Publicado: (2021)

Novel innovative computer-based test (Inno-CBT) item types for national licensing examinations for health care professionals
por: Chun, Kwang-Hoon, et al.
Publicado: (2023)

Intensity of antiplatelet therapy and percutaneous coronary intervention
por: Aronow, Wilbert S
Publicado: (2009)

Dual Antiplatelet Therapy in Coronary Artery Disease
por: Sharma, Raghav, et al.
Publicado: (2020)

Effect of Catechol Content in Catechol-Conjugated Dextrans on Antiplatelet Performance
por: Jeong, Yeonwoo, et al.
Publicado: (2017)

Iron deficiency anemia as a predictor of coronary artery abnormalities in Kawasaki disease
por: Kim, Sohyun, et al.
Publicado: (2019)

Factors affecting medication adherence in elderly people
por: Jin, Hyekyung, et al.
Publicado: (2016)

Qualitative Analysis of Proteins in Two Snake Venoms, Gloydius Blomhoffii and Agkistrodon Acutus
por: Ha, Su-Jeong, et al.
Publicado: (2022)

Secretory SERPINE1 Expression Is Increased by Antiplatelet Therapy, Inducing MMP1 Expression and Increasing Colon Cancer Metastasis
por: Kim, Won-Tae, et al.
Publicado: (2022)

Erratum: Correction of Text in the Article “Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI”
por: Ki, You-Jeong, et al.
Publicado: (2022)

Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent
por: Yoon, Yong-Hoon, et al.
Publicado: (2022)

Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation?
por: Abdulrahman, Balen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v01756sg69sk6ppi465vf8cm2f